2nd Quarter - Report

ALKERMES, INC. for ALKERMES, INC.

Period 2nd Quarter 2012 Filed Jul 20, 2012 Signed by Kathryn L. Biberstein, General Counsel

Official filing
Firm
ALKERMES, INC.
Client
ALKERMES, INC.
Income
—
Expenses
$30,147
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Introduction to Vivitrol. Discuss need for educational resources and public health matters.

LobbyistCovered position, as disclosed
ROBERT FORMAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Substance Abuse & Mental Health Services Administration (SAMHSA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.